WILLIAMS AND JENSEN, PLLC

Lobbying for AMGEN, INC. · An American multinational biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 21, 2025

Lobbying activity 6

Health Issues

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular health. Pharmacy benefit manager reform proposals.

Medicare/Medicaid

General education about policies impacting pharmaceutical development, approval, reimbursement, Medicare Part D and Medicare Part B, and 340B policies. Pharmacy benefit manager reform proposals.

Taxation/Internal Revenue Code

Tax issues related to the pharmaceutical industry.

Budget/Appropriations

Policies impacting disease prevention.

Labor Issues/Antitrust/Workplace

Issues related to antitrust legislation

Issues related to patent protections.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.